Cargando…
Identification and Validation of a Novel 2-LncRNAs Signature Associated with m6A Regulation in Colorectal Cancer
Colorectal cancer (CRC) is one of the most common tumors in the digestive system, and it is urgent to identify a new biomarker for the diagnosis and treatment of CRC. N6-methyladenosine (m6A) is an abundant mRNA modification and is almost involved in every aspect of physiological processes. In this...
Autores principales: | Wang, Kangchun, Zhao, Bei, Liang, Yu, Ma, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692696/ https://www.ncbi.nlm.nih.gov/pubmed/34976168 http://dx.doi.org/10.7150/jca.64817 |
Ejemplares similares
-
Identification and validation of an inflammation-related lncRNAs signature for improving outcomes of patients in colorectal cancer
por: Huang, Mengjia, et al.
Publicado: (2022) -
Pyroptosis-related lncRNAs: A novel prognosis signature of colorectal cancer
por: Cai, Xing, et al.
Publicado: (2022) -
Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer
por: Song, Yang, et al.
Publicado: (2022) -
Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022) -
Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer
por: Zheng, Jianfeng, et al.
Publicado: (2021)